BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16862819)

  • 1. Targeting sarcoplasmic reticulum calcium handling proteins as therapy for cardiac disease.
    Gregory KN; Kranias EG
    Hellenic J Cardiol; 2006; 47(3):132-43. PubMed ID: 16862819
    [No Abstract]   [Full Text] [Related]  

  • 2. Modulation of ryanodine receptor by luminal calcium and accessory proteins in health and cardiac disease.
    Györke S; Terentyev D
    Cardiovasc Res; 2008 Jan; 77(2):245-55. PubMed ID: 18006456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Junctin - the quiet achiever.
    Dulhunty A; Wei L; Beard N
    J Physiol; 2009 Jul; 587(Pt 13):3135-7. PubMed ID: 19567751
    [No Abstract]   [Full Text] [Related]  

  • 4. New roles of calsequestrin and triadin in cardiac muscle.
    Knollmann BC
    J Physiol; 2009 Jul; 587(Pt 13):3081-7. PubMed ID: 19451205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triadin overexpression stimulates excitation-contraction coupling and increases predisposition to cellular arrhythmia in cardiac myocytes.
    Terentyev D; Cala SE; Houle TD; Viatchenko-Karpinski S; Gyorke I; Terentyeva R; Williams SC; Gyorke S
    Circ Res; 2005 Apr; 96(6):651-8. PubMed ID: 15731460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Function and role of the sarcoplasmic reticulum in heart disease].
    Reyes-Juárez JL; Zarain-Herzberg A
    Arch Cardiol Mex; 2006; 76 Suppl 4():S18-32. PubMed ID: 17469332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of muscle ryanodine receptor calcium release channels by proteins in the sarcoplasmic reticulum lumen.
    Beard NA; Wei L; Dulhunty AF
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):340-5. PubMed ID: 19278523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triadin: the new player on excitation-contraction coupling block.
    Morad M; Cleemann L; Knollmann BC
    Circ Res; 2005 Apr; 96(6):607-9. PubMed ID: 15802617
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of Ca2+ signaling in transgenic mouse cardiac myocytes overexpressing calsequestrin.
    Jones LR; Suzuki YJ; Wang W; Kobayashi YM; Ramesh V; Franzini-Armstrong C; Cleemann L; Morad M
    J Clin Invest; 1998 Apr; 101(7):1385-93. PubMed ID: 9525981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing genes of sarcoplasmic reticulum proteins clarifies their roles in excitation-contraction coupling.
    Meissner G; Wang Y; Xu L; Eu JP
    J Physiol; 2009 Jul; 587(Pt 13):3089-90. PubMed ID: 19567747
    [No Abstract]   [Full Text] [Related]  

  • 11. Overexpression of junctin causes adaptive changes in cardiac myocyte Ca(2+) signaling.
    Kirchhefer U; Hanske G; Jones LR; Justus I; Kaestner L; Lipp P; Schmitz W; Neumann J
    Cell Calcium; 2006 Feb; 39(2):131-42. PubMed ID: 16289269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular properties of excitation-contraction coupling proteins in infant and adult human heart tissues.
    Jung DH; Lee CJ; Suh CK; You HJ; Kim DH
    Mol Cells; 2005 Aug; 20(1):51-6. PubMed ID: 16258241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early impairment of calcium handling and altered expression of junctin in hearts of mice overexpressing the beta1-adrenergic receptor.
    Engelhardt S; Boknik P; Keller U; Neumann J; Lohse MJ; Hein L
    FASEB J; 2001 Dec; 15(14):2718-20. PubMed ID: 11606476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory roles of junctin in sarcoplasmic reticulum calcium cycling and myocardial function.
    Fan GC; Yuan Q; Kranias EG
    Trends Cardiovasc Med; 2008 Jan; 18(1):1-5. PubMed ID: 18206802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple functions of junctin and junctate, two distinct isoforms of aspartyl beta-hydroxylase.
    Hong CS; Kwon SJ; Kim DH
    Biochem Biophys Res Commun; 2007 Oct; 362(1):1-4. PubMed ID: 17706594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation.
    Beard NA; Casarotto MG; Wei L; Varsányi M; Laver DR; Dulhunty AF
    Biophys J; 2005 May; 88(5):3444-54. PubMed ID: 15731387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Junctional sarcoplasmic reticulum transmembrane proteins in the heart.
    Müller FU; Kirchhefer U; Begrow F; Reinke U; Neumann J; Schmitz W
    Basic Res Cardiol; 2002; 97 Suppl 1():I52-5. PubMed ID: 12479235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calsequestrin and the calcium release channel of skeletal and cardiac muscle.
    Beard NA; Laver DR; Dulhunty AF
    Prog Biophys Mol Biol; 2004 May; 85(1):33-69. PubMed ID: 15050380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sarcoplasmic reticulum function and heart failure: a novel therapeutic target for heart failure].
    Minamisawa S; Ikeda Y
    Clin Calcium; 2006 Jan; 16(1):37-44. PubMed ID: 16397349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.
    Györke I; Hester N; Jones LR; Györke S
    Biophys J; 2004 Apr; 86(4):2121-8. PubMed ID: 15041652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.